The Effect of Fluvoxamine and Metformin for Fatigue in Patients With Long COVID : An Adaptive Randomized Trial - PubMed
8 hours ago
- #Long COVID
- #Fatigue Treatment
- #Clinical Trial
- Fluvoxamine significantly reduced fatigue in long COVID patients compared to placebo, with benefits sustained at 90 days.
- Metformin showed no significant benefit for fatigue in long COVID patients.
- Adverse events were less frequent with fluvoxamine (20.0%) than with metformin (28.8%) or placebo (29.7%), with severe events being rare.